Morningstar

Ansell Ltd ANN

Morningstar Rating
Unlock
Stock XASX Rating as of
A$32.15 −0.02 (0.06%)
View Full Chart
As of Delayed Price Closed

Company Report

View Archive

Narrow-Moat Ansell's Long-Term Trajectory Is Intact

Shane Ponraj

Ansell’s focus is on its key brands across industrial and healthcare settings. Each market is quite fragmented and Ansell’s market share varies by subsegment, but the firm has consistently held the highest or second-highest global market share in its key verticals. Competitors differ between the two segments but are either divisions of large global players or regional companies. Key industrial competitors are Honeywell, Globus, a private UK company, and ATG Gloves in the US In the healthcare segment, Halyard Health (spun out of Kimberly Clark in 2014) and Cardinal Health are major players.

Read Full Report

Price vs Fair Value

View History
ANN is trading at a 329% premium.
Price
A$32.15
Fair Value
A$86.80
Uncertainty
Medium
1-Star Price
A$61.87
5-Star Price
A$21.76
Economic Moat
Bnlqjb
Capital Allocation
Rydxfyryv

Bulls Say, Bears Say

Bulls

The fruits of Ansell’s restructuring efforts, being improved organic growth and expanding margins, started to become evident prepandemic in the first half of fiscal 2020.

Bears

Cost pressures, as well as manufacturing and supply chain disruptions are lingering with the threat of continued surges in covid-19.

Show More

News

View All

Trading Information

Previous Close Price
A$32.17
Day Range
A$31.96–32.18
52-Week Range
A$21.00–32.37
Bid/Ask
A$31.90 / A$32.20
Market Cap
A$4.69 Bil
Volume/Avg
160,487 / 416,197

Key Statistics

Price/Earnings (Normalized)
31.67
Price/Sales
1.68
Dividend Yield (Trailing)
1.79%
Dividend Yield (Forward)
1.79%
Total Yield
1.79%

Company Profile

Ansell is a leading supplier of protective gloves for use in healthcare and industrial settings, earning approximately 60% of revenue and 70% of operating profit from the healthcare segment and the remainder from the industrial segment. The company holds a large number of patents and the majority of sales come from its key branded product ranges. Ansell has a global manufacturing and distribution footprint and distributes via key partners as well as directly across more than 100 countries. In fiscal 2022, Ansell earned 45% of revenue in North America, 33% from Europe, Middle East and Africa, 14% across Asia-Pacific and the remaining 8% in Latin America.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Mid Core
Total Number of Employees
46,758
Website
https://www.ansell.com

Competitors

Valuation

View More
Metric
ANN
CHD
BDX
Price/Earnings (Normalized)
 31.6730.8018.67
Price/Book Value
 1.655.742.66
Price/Sales
 1.684.163.51
Price/Cash Flow
 10.8922.8218.92
Price/Earnings
ANN
CHD
BDX

Financial Strength

Metric
ANN
CHD
BDX
Quick Ratio
 2.650.941.20
Current Ratio
 3.841.531.85
Interest Coverage
 5.1711.104.20
Quick Ratio
ANN
CHD
BDX

Profitability

Metric
ANN
CHD
BDX
Return on Assets (Normalized)
 6.35%9.89%3.65%
Return on Equity (Normalized)
 10.41%21.07%7.60%
Return on Invested Capital (Normalized)
 8.24%14.62%5.30%
Return on Assets
ANN
CHD
BDX

Medical Instruments & Supplies Industry Comparables

Screen With Investor
1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Intuitive Surgical Inc
ISRG
WfvwthlkcFtmcs$171.3 Bil
 Becton Dickinson & Co
BDX
ZqnjybdfZvdxvk$68.9 Bil
 Alcon Inc
ALC
SjhczlhkFgrkbl$48.1 Bil
 ResMed Inc
RMD
YbycgrxjdTlnjwh$34.3 Bil
 Coloplast AS ADR
CLPBY
BvlrhtqsckVbcg$28.7 Bil
 West Pharmaceutical Services Inc
WST
HpwtxxxjPwccj$21.5 Bil
 The Cooper Companies Inc
COO
CmzcftdnLvdylx$21.1 Bil
 Hologic Inc
HOLX
RqzrjvpmHjvfy$18.6 Bil
 Baxter International Inc
BAX
VbbkywcJmnzf$18.5 Bil
 Align Technology Inc
ALGN
FdtjhzqDjkcfy$18.0 Bil

Sponsor Center